GBI Research’s medical devices report, “Pharmaceutical Analytical Services Outsourcing in India: Cost Savings, Product Quality and Shorter Delivery Times are Key Drivers” provides key data, information

Dallas, TX -- (SBWire) -- 12/03/2010 -- SandlerResearch announce Pharmaceutical Analytical Services Outsourcing in India: Cost Savings, Product Quality and Shorter Delivery Times are Key Drivers

Original Source : Pharmaceutical Outsourcing Market
http://www.sandlerresearch.org/reports/41367-pharmaceutical-analytical-services-outsourcing-in-india-cost-sav.html

Buy Now : Market Research
http://www.sandlerresearch.org/

Browse complete Report at : Pharmaceutical Analytical Services Outsourcing in India: Cost Savings, Product Quality and Shorter Delivery Times are Key Drivers
http://www.sandlerresearch.org/reports/41367-pharmaceutical-analytical-services-outsourcing-in-india-cost-sav.html

GBI Research’s medical devices report, “Pharmaceutical Analytical Services Outsourcing in India: Cost Savings, Product Quality and Shorter Delivery Times are Key Drivers” provides key data, information and analysis on the pharmaceutical analytical services outsourcing in india. The report provides market landscape, competitive landscape and market trends information on the segments within the analytical services market. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape, services technology offerings.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Scope

Key geographies covered is India
Market size and company share data the segments with pharmaceutical anlaytical laboratories market
Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2009.
Qualitative analysis of key market trends, market drivers, and restraints by each category within the pharmaceutical analytical services market.
The report also covers information on the leading market players, the competitive landscape, services and technologies.

Reasons to buy

Develop business strategies by understanding the trends and developments that are driving the Indian pharmaceutical analytical services market.
Design and develop your product development, marketing and sales strategies.
Exploit M&A opportunities by identifying market players with the promising products
Develop market-entry and market expansion strategies.
Identify key players best positioned to take advantage of the emerging market opportunities.
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
What’s the next being thing in the pharmaceutical analytical services market? – Identify, understand and capitalize.
Make more informed business decisions from the insightful and in-depth analysis of the Indian pharmaceutical analytical services market and the factors shaping it.

1 Table of Contents 4
1.1 List of Tables 6
1.2 List of Figures 6

2 Introduction 7
2.1 GBI Research Report Guidance 8

3 Background: 9
3.1 Major Services under Pharmaceutical Analytical Services 10
3.1.1 Impurity Profile 10
3.1.2 Analytical Method Development and Validations 10
3.1.3 Particle Size Distribution 10

4 Pharmaceutical Drug Discovery Outsourcing Market: Market Characterization 11
4.1 Market Share and Market Size 11
4.2 Pharmaceutical Drug Discovery Outsourcing Market, India, Revenue ($bn), 2004-2009 11
4.3 Pharmaceutical Drug Discovery Outsourcing Market, India, Revenue ($bn), 2009-2016 12
4.4 Forces that Drive Drug Discovery in India and China 14
4.4.1 Declining R&D Productivity, Especially for Big Pharma 14

5 Outsourcing Plan for Pharmaceutical Companies 16
5.1 Why India and China? 18
5.1.1 Availability of Skilled Manpower 18
5.1.2 Improved IP Protection in India and China 19
5.1.3 Government Support for Drug Discovery Development 20
5.1.4 SWOT Analysis of the Drug Discovery Industry in India 22
5.1.5 Conclusion 23

6 IP Protection in India and China – Improved IP Protection to Encourage Innovation 24
6.1 Patent Act 2005 – First Step towards Improving IP Protection 25
6.2 IPR Enforcement Rules, 2007 26
6.3 Trademarks Bill 2007 26
6.4 Drugs and Cosmetics Act (Amendment) 2008 27
6.5 EIPR (Enforcers of Intellectual Property Rights) – Ensuring IPR Laws Implementation in India 27

7 Government and Regulatory Support in India – Strong Support to Research Institutes and Small Companies 29
7.1 Government/Regulatory Support for Drug Discovery in India 29
7.1.1 Open Source Drug Discovery 29
7.1.2 Drug Development Promotion Board: Encouraging a PPP Model for Drug Discovery and Development 30
7.1.3 Technology Development Board: Supporting Technology Oriented Projects 31
7.1.4 NMITLI (New Millennium Indian Technology Leadership Initiative) Scheme 32

8 Pharmaceutical Analytical Services Outsourcing Market, Market Dynamics 33
8.1 Pharmaceutical Analytical Services Outsourcing Market, Market Trends 33
8.1.1 Pricing Pressures Driving Outsourcing of Pharmaceutical Analytical Work to Low Cost Destinations 33
8.1.2 Flexibility Offered by Companies in Terms of Resource and Manpower Allocation Contributing Towards Increased Outsourcing 33
8.1.3 Shared Risk Concept Encourages Greater Outsourcing of Drug Development 33
8.2 Pharmaceutical Analytical Services Outsourcing Market, Market Drivers 33
8.2.1 Lower Cost is a Key Driver towards Chemistry Outsourcing to Asian CROs 33
8.2.2 Demand for Shorter Research Cycle Driving Outsourcing of Chemistry Services 34
8.3 Pharmaceutical Analytical Services Outsourcing Market, Market Restraints 34
8.3.1 Intellectual Property and Legal Landscape is a Key Restraint in the Growth of Outsourcing of Pharmaceutical Analytical Services to Asian Countries 34

9 Market Opportunity and Risk Assesment 35

10 Future Outlook 36

11 Major Indian Drug Discovery Companies – Different Business Models to Provide Similar Services 38
11.1 Indian Drug Discovery Business Model – R&D Hive-off for Better Services and Risk Reduction 38
11.2 Jubilant Organosys’ Jubilant Biosys 39
11.2.1 About Jubilant Organosys 39
11.2.2 Major Drug Discovery Deals 40
11.3 Dr. Reddy’s Aurigene 41
11.3.1 About Dr. Reddy’s 41
11.3.2 Aurigene 41
11.3.3 Major Drug Discovery Deals 42
11.4 Biocon’s Syngene 43
11.4.1 About Biocon 43
11.4.2 Syngene 43
11.4.3 Major Drug Discovery Deals 44
11.5 GVK BIO 45
11.5.1 Business Description 45
11.5.2 Major Drug Discovery Deals 46
11.6 Advinus Therapeutics 47
11.6.1 Business Description 47
11.6.2 Major Drug Discovery Deals 48
11.7 Sipra Labs 49
11.7.1 Business Description 49
11.8 Sai Advantium 50
11.8.1 Business Description 50

12 Deals Analysis – Equal Thrust From Big Pharma and Mid-Size Pharma 51
12.1 Number of Discovery Research Deals – Increased Activity by Big and Mid-size Pharma 51
12.2 Deals by Major Therapeutic Area – Oncology and Metabolic Disorders 52
12.3 Deals by Client Type – Mid-size Pharma Deals Rising in India and China 53
12.4 Major Drug Discovery Deals 55
12.4.1 Amgen with Jubilant Biosys: Supporting Early Stage Preclinical Development Effort to Provide Cost-Effective Drugs 55
12.4.2 Bristol-Myers Squibb with Syngene: Dedicated Research Facility for Discovery and Early Drug Development 55
12.4.3 Novartis with Aurigene: Generating Pre-clinical Candidates for Oncology-focused Program 55
12.4.4 Merck & Co with Advinus Therapeutics: To Develop Clinically Validated Drug Candidates for Metabolic Disorders 55
12.5 Conclusion 56

13 Future Challenges – Financial and Intellectual Obstacles to Impede the Future Growth 57
13.1 Financial Problems will Make it Difficult to Sustain the Growth 57
13.2 Talent Shortage in Early Stage Chemistry and Biology 57
13.3 Competition from Europe as an Alternative Discovery Research Destination 58
13.4 Conclusion 59

14 Key Takeaway 60

15 Appendix 61
15.1 Definitions 61
15.2 Market Definitions 61
15.3 Acronyms 61
15.4 Research Methodology 64
15.4.1 Secondary Research 64
15.4.2 Primary Research 64
15.4.3 Models 65
15.4.4 Forecasts 65
15.4.5 Expert Panels 65
15.5 Contact Us 65
15.6 Disclaimer 65

ABBREVIATIONS

Browse all : Medical Devices
http://www.sandlerresearch.org/market-research/medical-devices/

Browse all : GBI Research
http://www.sandlerresearch.org/publishers/gbi-research/

Browse all : Newly Published
http://www.sandlerresearch.org/LatestReport.aspx

Related Reports :

China’s key position in global service delivery
http://www.sandlerresearch.org/reports/9410-chinas-key-position-in-global-service-delivery.html

2009 Top IT Software Testing and Quality Assurance Outsourcing Vendors, Black Book Survey 2009 Results
http://www.sandlerresearch.org/reports/7322-2009-top-it-software-testing-and-quality-assurance-outsourcing-ve.html

Real-time Location Services (RTLS): Applications, Services and Company Analysis
http://www.sandlerresearch.org/reports/11050-real-time-location-services-rtls-applications-services-and-co.html

LED Driver ICs: Application Drivers, Technology Developments & Product Introduction Trends
http://www.sandlerresearch.org/reports/16394-led-driver-ics-application-drivers-technology-developments-pr.html

Cloud-computing quality of service in perspective
http://www.sandlerresearch.org/reports/25822-cloud-computing-quality-of-service-in-perspective.html

About Us:
Sandler Research houses a comprehensive online library of more than 10,000 reports, in-depth market research studies of 5000+ micro markets, and 25 industry specific websites. The reports are analytically and statistically rich, and offer a comprehensive view of the dynamic market scenario across the globe.
Our client list boasts of many eminent publishers of such reports from across the world. As a third-party reseller of market research reports, we employ various marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques, in order to generate better revenues for our clients, entailing positive and robust results.
We also provide 24/7 online and offline support to our customers

Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Website: http://www.sandlerresearch.org
Blog: http://sandlerresearch.blogspot.com/